Schedule 13G ownership disclosure
ENSYSCE BIOSCIENCES INC
Common Stock, par value $0.0001 per share · CUSIP: 293602504
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 86,666 · Class: 5.3%
- Joseph Edelman
Shares: 86,666 · Class: 5.3%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 86,666 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-050419
- Form type
- SCHEDULE 13G/A
- Filer
- Ensysce Biosciences, Inc.
- CIK
- CIK 1716947
- Filed
- Apr 03, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership